These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866 [TBL] [Abstract][Full Text] [Related]
7. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis. Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391 [TBL] [Abstract][Full Text] [Related]
8. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis. Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152 [TBL] [Abstract][Full Text] [Related]
9. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy. Amos RS; Bax DE Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830 [TBL] [Abstract][Full Text] [Related]
10. HLA DR antigens and disease expression in rheumatoid arthritis. Griffin AJ; Wooley P; Panayi GS; Batchelor JR Ann Rheum Dis; 1984 Apr; 43(2):218-21. PubMed ID: 6424587 [TBL] [Abstract][Full Text] [Related]
11. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone. Grindulis KA; McConkey B Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295 [TBL] [Abstract][Full Text] [Related]
12. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269 [TBL] [Abstract][Full Text] [Related]
13. Leucopenia during sulphasalazine treatment for rheumatoid arthritis. Marabani M; Madhok R; Capell HA; Hunter JA Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110 [TBL] [Abstract][Full Text] [Related]
14. HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis. Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP Tissue Antigens; 1985 Jul; 26(1):35-40. PubMed ID: 3929421 [TBL] [Abstract][Full Text] [Related]
15. HLA and the response to gold therapy in rheumatoid arthritis. Carette S; Lang JY; Mathieu JP; Roy R; Morissette J Arthritis Rheum; 1987 Feb; 30(2):233. PubMed ID: 3103634 [No Abstract] [Full Text] [Related]
16. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Dahlqvist SR; Ström H; Bjelle A; Möller E Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529 [TBL] [Abstract][Full Text] [Related]
18. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Pullar T; Hunter JA; Capell HA Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117 [TBL] [Abstract][Full Text] [Related]
19. HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine. Nuotio P; Nissilä M; Ilonen J Scand J Rheumatol; 1986; 15(3):255-8. PubMed ID: 3492038 [TBL] [Abstract][Full Text] [Related]
20. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis]. Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059 [No Abstract] [Full Text] [Related] [Next] [New Search]